All stocks ยท INDGN
IL

Indegene Limited

INDGN BSE Healthcare

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally. It operates through Enterprise Medical Solutions, Enterprise โ€ฆ

ISIN INE065X01017
Listed โ€”
Quarters tracked 13
Filings 8 docs

About

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, and Other segments. The company provides AI-embedded commercialization services for biopharmaceutical, emerging biotech, and medical devices companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms, as well as provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Further, it engages in the professional, and scientific and technical activities. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Key Metrics

as of Sep 2026
Market Cap14,492 Cr
P/E34.80
Div Yield0.37 %
Book Valueโ‚น130.00
52w Highโ‚น616.00
52w Lowโ‚น414.00
Face Valueโ‚น2.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 341.00 368.00 290.00 307.00 256.00 267.00 287.00 282.00 259.00 272.00 260.00 260.00 252.00
Expenses 280.00 265.00 252.00 236.00 219.00 227.00 235.00 235.00 219.00 226.00 223.00 217.00 215.00
Operating Profit 60.00 103.00 38.00 71.00 37.00 40.00 52.00 46.00 40.00 46.00 37.00 43.00 38.00
OPM % 18.00 28.00 13.00 23.00 14.00 15.00 18.00 16.00 15.00 17.00 14.00 17.00 15.00
Other Income 34.00 6.00 23.00 18.00 32.00 35.00 22.00 22.00 14.00 23.00 12.00 6.00 12.00
Depreciation 11.00 11.00 10.00 9.00 7.00 7.00 6.00 6.00 7.00 8.00 6.00 8.00 9.00
Interest 3.00 3.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00
Profit before tax 80.00 95.00 49.00 78.00 60.00 66.00 66.00 61.00 45.00 60.00 41.00 39.00 39.00
Tax % 25.00 24.00 29.00 23.00 25.00 18.00 25.00 27.00 28.00 19.00 27.00 26.00 24.00
Net Profit 60.00 72.00 35.00 60.00 45.00 54.00 50.00 45.00 33.00 49.00 30.00 29.00 30.00
EPS in Rs 2.49 2.99 1.45 2.49 1.88 2.26 2.08 1.87 1.36 2.20 1.33 1.32 1.33

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales 1,221.001,094.001,046.001,006.00837.00511.00334.00282.00
Expenses 972.00913.00878.00828.00668.00361.00249.00230.00
Operating Profit 248.00180.00168.00178.00169.00150.0086.0053.00
OPM % 20.0017.0016.0018.0020.0029.0026.0019.00
Other Income 78.0090.0050.0037.0028.0030.00-24.0012.00
Interest 9.006.007.006.003.004.003.001.00
Depreciation 36.0026.0031.0032.0024.0018.0013.004.00
Profit before tax 281.00238.00181.00177.00170.00159.0046.0059.00
Tax % 25.0024.0024.0026.0022.0017.0030.0014.00
Net Profit 212.00181.00138.00130.00133.00132.0032.0051.00
EPS in Rs 8.807.556.205.87755.26843.58202.30324.22
Dividend Payout % 26.0026.000.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital 48.0048.0044.0044.000.400.300.300.31
Reserves 2,032.001,840.00909.00751.00650.00254.00-3.00158.00
Borrowings 70.0027.0038.0051.0044.0023.00362.00106.00
Other Liabilities 332.00234.00228.00191.00156.0096.0072.0057.00
Total Liabilities 2,482.002,150.001,220.001,038.00850.00373.00431.00322.00
Fixed Assets 113.0053.0056.0078.0072.0041.0031.008.00
CWIP 12.004.000.000.000.000.000.000.00
Investments 1,318.00975.00624.00400.00203.0083.00251.00134.00
Other Assets 1,039.001,119.00540.00559.00575.00249.00148.00180.00
Total Assets 2,482.002,150.001,220.001,038.00850.00373.00431.00322.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Cash from Operating Activity 346.00129.00176.0082.0038.0053.0090.0062.00
Cash from Investing Activity -270.00-824.00-189.00-51.00-267.00-34.00-51.00-70.00
Cash from Financing Activity -63.00717.00-16.00-17.00245.00-37.00-18.0015.00
Net Cash Flow 13.0022.00-29.0014.0016.00-18.0020.008.00
Free Cash Flow 302.00112.00166.0066.0017.0035.0084.0060.00
CFO/OP % 159.00111.00134.0070.0044.0052.00122.00145.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days 86.00140.00132.00145.00152.00125.0065.0065.00
Cash Conversion Cycle 86.00140.00132.00145.00152.00125.0065.0065.00
Working Capital Days 51.00121.00104.00113.00103.0076.00-12.0016.00
ROCE % 14.0017.0018.0024.0036.0049.0028.00โ€”

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024
FIIs 9.92 10.27 11.48 11.30 10.04 5.24 5.03 4.82 3.79
DIIs 8.74 8.29 8.06 6.95 7.20 4.96 3.99 3.17 3.84
Public 81.34 81.43 80.44 81.74 82.75 89.80 91.01 92.01 92.38
No. of Shareholders 138,533 142,119 147,182 151,809 151,997 144,708 153,789 151,440 203,599

Corporate Actions

3 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 31 Jul 2026 31 Jul 2026 โ€” 2.25
Dividend 13 Jun 2025 13 Jun 2025 โ€” 2.00
Other 29 Aug 2024 โ€” โ€” โ€” Annual General Meeting

Announcements

5 filings